Perna et al. suggested four possible combinatorial pairings (CD33+ADGRE, CLEC12A+CCR1, CD33+CD70, and LILRB+CLEC12A) to target AML with an algorithm integrating proteomics and transcriptomics [35]. This evidence concerns the gene CLEC12A and acute myeloid leukemia.